☐ |
Preliminary Proxy Statement
|
☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
☐ |
Definitive Proxy Statement
|
☒ |
Definitive Additional Materials
|
☐ |
Soliciting Material Pursuant to Rule 14a-12
|
☒ |
No fee required
|
☐ |
Fee computed on table below per Exchange Act Rules 14a-6(i)(l) and 0-11
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
(2) |
Aggregate number of securities to which transaction applies:
|
|
(3) |
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
(4) |
Proposed maximum aggregate value of transaction:
|
|
(5) |
Total fee paid:
|
☐ |
Fee paid previously with preliminary materials.
|
☐ |
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-1l(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
(1)
|
Amount Previously Paid:
|
|
(2) |
Form, Schedule or Registration Statement No.:
|
|
(3) |
Filing Party:
|
|
(4) | Date Filed: |
IMPORTANT INFORMATION FROM
YOUR BOARD OF DIRECTORS |
●
|
On October 23, 2015, Rx Investor initially expressed interest in acquiring the Company at a price "anticipated to be in the range of $0.16 to $0.20 per share."
|
●
|
While Rx Investor increased their initial price, we believe it was still too low. Your Board asked Rx Investor to show they had sufficient funds to complete the transaction, but they never did so.
|
●
|
We publicly announced that we intend to hire an investment banker to explore all strategic options to maximize shareholder value, including a strategic partnership with a larger, well-capitalized entity or a sale of the Company (see enclosed press release).
|
●
|
We believe this is the best way to recognize the Company's value and enormous potential.
|
●
|
The value of your common stock has more than DOUBLED since the end of 2015 and has more than TRIPLED since the end of 2014 under your current Board of Directors' and management's direction and strategy.
|
●
|
Mr. Michael E. Peppel was convicted of violating federal securities laws, was imprisoned for nearly two years, was required to pay a $5 million fine, and is banned for life from serving as a director or officer of any public company.
|
●
|
The RIVC Group engaged Mr. Peppel as a consultant with respect to their efforts to acquire control of your Company!
|
●
|
"Michael Peppel engaged in a deliberate scheme to defraud millions of dollars from investors" in MCSI, Inc.
|
●
|
"Mr. Peppel's offenses are serious. His well-planned and deliberate actions cost investors not only millions but also hundreds, if not thousands, of jobs for people in Ohio."
|
●
|
"Mr. Peppel charged to his Healthwarehouse.com corporate credit card over $300,000 in personal expenses."
|
●
|
"Whatever his role at Healthwarehouse.com, Mr. Peppel exploited it to the benefit of his interests and to the detriment of that company and its shareholders."
|
●
|
"Without the prior approval or knowledge of the Board of Directors, he arranged for products from his wife's company to be sold through Healthwarehouse.com's website at cost (i.e., at the price Healthwarehouse.com paid for the product). While this arrangement undoubtedly advanced his own interests and that of his wife, it made little business sense for Healthwarehouse.com. When finally advised of this questionable arrangement, the Board of Directors immediately ordered its termination."
|
●
|
Cape Bear is an entity over which Mr. Peppel "maintained de facto control."
|
●
|
"Additionally, it appears that, in selling stock, Cape Bear may have exploited inside information concerning Healthwarehouse.com. Cape Bear, for example, sold shares of Healthwarehouse.com stock shortly before Mr. Peppel's credit card scheme was disclosed to the SEC."
|
●
|
Cape Bears Partners is a member of the RIVC Group.
|
●
|
Michael E. Peppel is a consultant to the RIVC Group.
|
●
|
Your Board believes that your Company and its shareholders have suffered enough from the prior activities of Mr. Peppel.
|
●
|
The RIVC Group is seeking to elect four directors at the meeting, which will give them control of your Board and control of your Company!
|
●
|
The RIVC Group is not planning to make any payment to existing shareholders or to pay any control premium to our shareholders.
|
●
|
We believe it is appropriate for anyone seeking control of your Company to pay a control premium, even if they are not required by law to do so.
|
●
|
The RIVC Group wants their nominees if elected to have the Company pay all of the costs of the RIVC Group to acquire control of your Company. They also state that such payment to them is not expected to be submitted to shareholders for approval!
|
●
|
We do not believe it is appropriate for the RIVC Group to have their expenses paid by the Company without shareholder approval of such payment.
|
●
|
We offered the RIVC Group a seat on your Board in an attempt to avoid a very costly and disruptive proxy fight, but this offer was rejected by the group. The RIVC Group said they wanted all four Board seats.
|
●
|
Net consumer sales were $2,302,215 for the June 30, 2016 quarter, an increase of $779,275 or 51.5% compared to the 2nd quarter of 2015, due to continuing national press coverage and repeat business.
|
●
|
Core prescription sales were $1,810,053 for the June 30, 2016 quarter, an increase of $598,002 or 49.3% compared to the 2nd quarter of 2015, the highest level in the Company's history.
|
●
|
New customers grew 140% in the June 30, 2016 quarter compared to the 2nd quarter of 2015, and gross margins were 64.3% for the June 30, 2016 quarter.
|
●
|
Your Company is a 4 time Bizrate Circle of Excellence award winner, putting it in the top 2.9% of more than 4,700 retailers for customer service and satisfaction.
|
●
|
We believe the Company's solid results and consumer focused strategy are driving favorable press coverage!
|
●
|
Your Board of Directors intends to maximize value for all shareholders and intends to explore all strategic options, including a sale of the Company.
|
●
|
Your Board of Directors recommends that you vote FOR each of the proposals on the enclosed WHITE proxy card.
|
●
|
The future of your Company is at stake, and it is important that you vote, no matter how many shares you own.
|
●
|
You may vote by signing and dating the enclosed WHITE proxy card by returning it in the enclosed postage-paid envelope. Please remember to SIGN and DATE your card when you return it.
|
●
|
You may also vote over the Internet or by telephone by following the directions on your WHITE proxy card.
|
●
|
If your shares are held through a broker, bank or other nominee, you must return your voting instructions to that entity in order to have your vote counted. You can do so by sending a WHITE voting card instruction to that entity or by voting over the Internet or by telephone by following the instructions from the broker, bank or nominee.
|
●
|
Your Board recommends that you not sign or return any Blue proxy card that you receive from the RIVC Group. You should not sign a Blue proxy card to vote against the RIVC Group nominees, as doing do will cancel your vote in favor of your Board's nominees.
|
●
|
If you have already signed a Blue proxy card, please sign the enclosed WHITE proxy card, as only your latest dated proxy counts.
|